Select Medical (SEM)
(Delayed Data from NYSE)
$33.70 USD
+0.56 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $33.68 -0.02 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$33.70 USD
+0.56 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $33.68 -0.02 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
Zacks News
Select Medical (SEM) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 86.67% and 5.24%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Select Medical (SEM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Universal Health (UHS) to Report Q3 Results: What to Expect
by Zacks Equity Research
Universal Health's (UHS) third-quarter earnings results are likely to reflect depressed revenues and weak admissions.
Centene's (CNC) Q3 Earnings Improve Y/Y on High Revenues
by Zacks Equity Research
Centene's (CNC) third-quarter results reflect higher revenues and managed care membership.
Anthem (ANTM) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Anthem's (ANTM) third-quarter earnings results are likely to reflect elevated costs and a softness in Commercial business line.
Will Covid-Led Higher Demand Aid Teladoc's (TDOC) Q3 Earnings?
by Zacks Equity Research
A surge in demand for virtual health care services is likely to have contributed to Teladoc's (TDOC) earnings in Q3
Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Ranked Growth Stocks to Buy for September 29th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 29th
Select Medical Enters Into Joint Venture With Rush University
by Zacks Equity Research
Select Medical (SEM) forms a joint venture with Rush University to manage healthcare operations at facilities in Chicago and Northwest Indiana area.
Centene (CNC) Offers Senior Unsecured Notes Valued $2.2B
by Zacks Equity Research
Centene (CNC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.
Zacks.com featured highlights include: LZB, SEM, UCTT, QFIN and BERY
by Zacks Equity Research
Zacks.com featured highlights include: LZB, SEM, UCTT, QFIN and BERY
5 Must-Buy Stocks Offering High Earnings Yield
by Rimmi Singhi
The earnings potential of a stock is an important consideration while making investment decisions. This makes the earnings yield ratio a handy tool for stock selection.
Top Ranked Growth Stocks to Buy for September 21st
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 21st
Top Ranked Growth Stocks to Buy for September 17th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 17th
Here's Why You Should Retain Cigna Stock in Your Portfolio
by Zacks Equity Research
Cigna (CI) is poised for growth, given its continuous efforts to innovate solutions and growing suite of telehealth services.
What Makes Select Medical (SEM) an Attractive Investment Pick
by Zacks Equity Research
Solid operating fundamentals and rising earnings estimate make Select Medical (SEM) a lucrative stock.
UnitedHealthcare, Canopy Health Come Up With New Health Plan
by Zacks Equity Research
UnitedHealth Group's (UNH) business, UnitedHealthcare, expands collaboration with Canopy Health by rolling out a health plan for benefiting people in the Bay Area.
Top Ranked Growth Stocks to Buy for September 11th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 11th
Is Select Medical (SEM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Magellan, Livongo's Solution to Enhance Behavioral Health
by Zacks Equity Research
Magellan (MGLN) collaborates with Livongo, which provides Magellan customers and members access to a digital self-care solution, Livongo for Behavioral Health.
Top Ranked Growth Stocks to Buy for September 9th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 9th
The Zacks Analyst Blog Highlights: HUM, SEM, UHS and FSNUY
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HUM, SEM, UHS and FSNUY
Here's Why You Should Hold Magellan Stock in Your Portfolio
by Zacks Equity Research
Magellan (MGLN) continues to benefit from cost-cutting initiatives and impressive capital position.
How to Invest After the Market Selloff
by Sejuti Banerjea
Tried and tested methods always work best when you're faced with increased uncertainty and volatility.
Tenet Healthcare Offers Senior Unsecured Notes Worth $2.5B
by Zacks Equity Research
Tenet Healthcare (THC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.